The chemical class of AChRα4 inhibitors comprises a diverse array of compounds that can either directly or indirectly modulate the function of the alpha-4 subunit of nicotinic acetylcholine receptors (AChRα4). These inhibitors play a pivotal role in regulating cholinergic signaling and can influence a wide range of physiological and cellular processes. Some of the inhibitors in this class, such as Methyllycaconitine and α-Bungarotoxin, act as direct competitive antagonists by binding specifically to AChRα4. By doing so, they disrupt acetylcholine from activating the receptor, effectively blocking cholinergic transmission. These compounds have been extensively studied for their ability to target AChRα4 in the nervous system, leading to insights into neuromuscular function and the role of AChRα4 in synaptic signaling.
In addition to direct antagonists, several chemicals in the list act as indirect inhibitors of AChRα4. For instance, Dhurrin influences the glycolysis pathway, resulting in reduced glycolytic activity. This reduction can indirectly downregulate AChRα4 expression, impacting the availability of acetylcholine for receptor activation. Similarly, α-Conotoxin PIA modulates calcium channels, reducing calcium influx, which indirectly inhibits AChRα4 function by altering the calcium-dependent processes that are essential for cholinergic transmission. Furthermore, other compounds in this chemical class, such as Tubocurarine and Gephyrotoxin, affect neuromuscular transmission by targeting different components of the neuromuscular junction, ultimately leading to an indirect inhibition of AChRα4. These diverse mechanisms of action within the AChRα4 inhibitors class underscore the complex interplay of signaling pathways and cellular processes that regulate cholinergic neurotransmission. Researchers continue to explore the applications of these inhibitors in the context of neurological and neuromuscular disorders, shedding light on the intricacies of AChRα4 function and its role in maintaining proper neuromuscular communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methyllycaconitine citrate | 112825-05-5 | sc-253043 sc-253043A | 5 mg 25 mg | $119.00 $406.00 | 2 | |
A direct competitive antagonist of AChRα4, binding to the receptor and preventing acetylcholine from activating it. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
Another direct competitive antagonist, α-Bungarotoxin specifically targets AChRα4 and inhibits its activation by acetylcholine. | ||||||
Hemicholinium-3 | 312-45-8 | sc-252873 sc-252873A | 100 mg 500 mg | $84.00 $413.00 | ||
Inhibits choline uptake, which indirectly reduces the availability of acetylcholine and subsequently inhibits AChRα4 activation. | ||||||
Hexamethonium chloride | 60-25-3 | sc-263383 | 5 g | $32.00 | ||
Blocks ganglionic transmission, indirectly inhibiting AChRα4 by preventing synaptic acetylcholine release. | ||||||